Claiborne Cary J 4
4 · ADIAL PHARMACEUTICALS, INC. · Filed Dec 5, 2024
Insider Transaction Report
Form 4
Claiborne Cary J
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-12-05+350,000→ 350,000 totalExercise: $1.15Exp: 2034-12-04→ Common Stock (350,000 underlying)
Footnotes (1)
- [F1]The option vests pro rata on a monthly basis over 36 months commencing December 5, 2024.